{"gene":"COG5","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2003,"finding":"Drosophila Cog5 homologue (Fws) localizes to Golgi structures throughout spermatogenesis and is required for cleavage furrow ingression during spermatocyte cytokinesis, cell elongation in spermatids, and assembly of the Golgi-based acroblast, consistent with a role in facilitating vesicle traffic through the Golgi to support rapid increases in cell surface area.","method":"Loss-of-function genetic analysis, immunofluorescence localization, phenotypic analysis of dividing spermatocytes and differentiating spermatids","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with defined cellular phenotypes and direct localization; replicated across multiple developmental stages","pmids":["12529436"],"is_preprint":false},{"year":2002,"finding":"Mammalian Sec34 (a COG complex subunit) localizes to the Golgi apparatus, participates in ER-to-Golgi transport (anti-Sec34 antibodies inhibit VSVG transport in a semi-intact cell assay), and physically interacts with GTC-90 and ldlBp/ldlCp as part of the same multisubunit complex; direct interactions of Sec34 with ldlBp and ldlCp were demonstrated in vitro.","method":"Immunofluorescence, semi-intact cell transport assay with neutralizing antibodies, large-scale immunoprecipitation from rat liver cytosol, in vitro binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — functional blocking antibody in reconstituted transport assay plus direct in vitro binding, multiple orthogonal methods in single study","pmids":["11929878"],"is_preprint":false},{"year":2005,"finding":"COG5 (Cog5) forms a stable subcomplex with Cog6 and Cog7 (lobe B), distinct from the Cog1–4 (lobe A) subcomplex; Cog8 bridges both subcomplexes into the complete COG complex; Cog5 deficiency causes mild Golgi cisternae dilation and partial glycosylation defects but not the full spectrum seen with Cog1/Cog2 loss, indicating subunit-specific roles. Only one or two of the Cog1/Cog2-dependent GEAR proteins are also sensitive to Cog5 deficiency.","method":"RNA interference knockdown of Cog5 in HeLa cells, immunoblotting, gel filtration, immunofluorescence microscopy, comparison with Cog1/Cog2 null CHO cells and Cog7-deficient fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (gel filtration, immunoblot, immunofluorescence, functional glycosylation assay) with isogenic comparisons; supported by accompanying in vitro study","pmids":["16051600"],"is_preprint":false},{"year":2009,"finding":"Loss of COG5 protein (due to a splicing mutation causing exon skipping) delays retrograde Golgi-to-ER trafficking as measured by brefeldin-A treatment of patient fibroblasts, and causes defective N- and O-glycan sialylation; re-expression of wild-type COG5 cDNA restores normal trafficking kinetics.","method":"Brefeldin-A retrograde trafficking assay in patient fibroblasts, serum glycoprotein analysis, rescue by wild-type COG5 cDNA transfection","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — functional rescue experiment with defined cellular phenotype and multiple glycosylation readouts","pmids":["19690088"],"is_preprint":false},{"year":2014,"finding":"Crystal structure of the Cog5–Cog7 complex reveals that Cog5 adopts a CATCHR (complexes associated with tethering containing helical rods) fold, homologous to subunits of the Dsl1, exocyst, and GARP complexes. The Cog5–Cog7 interface is conserved from yeast to humans, and disruption of this interface in human cells causes defects in Golgi trafficking and glycosylation.","method":"X-ray crystallography of Cog5–Cog7 complex, biochemical interaction assays, functional studies in human cells with interface-disrupting mutations","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validated in functional cellular assays; multiple orthogonal methods","pmids":["25331899"],"is_preprint":false},{"year":2020,"finding":"COG5 variants cause fragmentation of the Golgi apparatus and upregulation of the UPR modulator PERK (PKR-like ER kinase), which in turn induces DNA damage in cultured cells and in murine retina, identifying a role for COG5 in maintaining ER protein homeostasis.","method":"Patient-derived cells with COG5 variants, immunofluorescence for Golgi morphology, western blotting for PERK and DNA damage markers, murine retinal analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple readouts (Golgi morphology, UPR activation, DNA damage) in patient cells and mouse model, but single lab","pmids":["33277529"],"is_preprint":false},{"year":2024,"finding":"A missense variant (p.Leu100Phe) in COG5 disrupts protein solubility and stability and abrogates the COG5–COG7 protein–protein interaction, as confirmed by co-immunoprecipitation in patient-derived cells.","method":"Co-immunoprecipitation in patient-derived cells, in silico structural analysis of COG5 variant effects on stability and solubility","journal":"Journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP from patient cells demonstrating loss of COG5–COG7 interaction, supported by in silico solubility/stability data","pmids":["38987656"],"is_preprint":false},{"year":2026,"finding":"COG5 deficiency leads to elevated cellular copper levels, which disrupts mitochondrial iron-sulfur cluster function and causes complex I assembly defects, resulting in impaired mitochondrial OXPHOS; these defects can be rescued by restoring COG5 expression or by copper chelation.","method":"Proteomic analysis of COG5-deficient and rescue cell models, biochemical validation of OXPHOS complex content, copper level measurements, copper chelator rescue experiments, patient-derived cells with COG5 variants","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical rescue by both genetic (COG5 re-expression) and pharmacological (copper chelator) means, with proteomic and functional OXPHOS readouts across multiple cell models","pmids":["41824529"],"is_preprint":false},{"year":2024,"finding":"In yeast, all lobe B COG subunits (Cog5–Cog8) are required for resistance to killer toxin K28; COG complex lobe B is needed for proper trafficking of the endolysosomal defence factor Ktd1, and its mis-localization in cog mutants accounts for hypersensitivity to the toxin beyond effects on surface glycosylation.","method":"High-throughput K28 sensitivity assay, fluorescence microscopy of Ktd1 localization in cog mutant yeast","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — functional assay plus direct localization in genetic mutants; preprint, yeast ortholog","pmids":["bio_10.1101_2024.12.20.629825"],"is_preprint":true}],"current_model":"COG5 is a lobe B subunit of the conserved oligomeric Golgi (COG) tethering complex that adopts a CATCHR fold and directly interacts with COG7; it mediates retrograde intra-Golgi trafficking to maintain Golgi glycosyltransferase localization and glycoprotein glycosylation, participates in ER-to-Golgi vesicle tethering, supports membrane remodeling during cytokinesis and cell elongation (in Drosophila), and additionally regulates cellular copper homeostasis to sustain mitochondrial OXPHOS complex I assembly."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing that the COG complex participates in ER-to-Golgi transport answered whether this tethering complex functions only in intra-Golgi recycling or also in anterograde traffic from the ER.","evidence":"Neutralizing anti-Sec34 antibodies inhibited VSVG transport in a semi-intact cell assay; co-IP and in vitro binding identified COG subunit interactions","pmids":["11929878"],"confidence":"High","gaps":["Specific contribution of COG5 versus other subunits to ER-to-Golgi tethering was not resolved","In vitro transport reconstitution with purified COG complex not performed"]},{"year":2003,"claim":"Demonstration that the Drosophila COG5 orthologue Fws is required for Golgi-dependent membrane remodeling during cytokinesis and spermatid elongation revealed that COG5 function extends beyond steady-state trafficking to rapid membrane expansion events.","evidence":"Loss-of-function mutant analysis with immunofluorescence localization in Drosophila spermatocytes and spermatids","pmids":["12529436"],"confidence":"High","gaps":["Whether mammalian COG5 has analogous roles in cytokinesis was not tested","Vesicle cargo identity at the cleavage furrow unknown"]},{"year":2005,"claim":"Mapping COG5 to a stable lobe B subcomplex (COG5–6–7) bridged to lobe A by COG8 defined the modular architecture of the COG complex and showed that lobe B loss produces milder glycosylation defects than lobe A loss.","evidence":"siRNA knockdown in HeLa cells combined with gel filtration, immunoblotting, and glycosylation analysis compared to Cog1/Cog2 null CHO cells","pmids":["16051600"],"confidence":"High","gaps":["Structural basis of the COG5–COG6 interaction within lobe B remained unresolved","Functional redundancy among lobe B subunits not fully tested"]},{"year":2009,"claim":"Identification of a COG5 splicing mutation in a CDG patient with defective retrograde Golgi trafficking, rescuable by wild-type COG5 re-expression, established COG5 as a disease gene and directly linked its function to glycosylation homeostasis in humans.","evidence":"Brefeldin-A trafficking assay in patient fibroblasts, serum glycoprotein profiling, and genetic rescue","pmids":["19690088"],"confidence":"High","gaps":["Mechanism by which partial COG5 loss selectively affects sialylation over other glycosylation steps unclear","Neurological pathogenesis not mechanistically explained"]},{"year":2014,"claim":"The crystal structure of the COG5–COG7 complex revealed a CATCHR fold for COG5 and showed that the conserved COG5–COG7 interface is essential for Golgi trafficking, unifying COG with other CATCHR tethering complexes structurally.","evidence":"X-ray crystallography, interface-disrupting mutagenesis with functional assays in human cells","pmids":["25331899"],"confidence":"High","gaps":["Full-length COG5 structure not obtained","How COG5 engages SNARE or Rab proteins was not resolved"]},{"year":2020,"claim":"Discovery that COG5 variants cause Golgi fragmentation and PERK-mediated UPR activation leading to DNA damage expanded the downstream consequences of COG5 dysfunction beyond glycosylation to ER proteostasis and genome integrity.","evidence":"Patient-derived cells and murine retina analyzed by immunofluorescence, western blot for PERK and DNA damage markers","pmids":["33277529"],"confidence":"Medium","gaps":["Causal chain from Golgi fragmentation to PERK activation not mechanistically dissected","Whether UPR activation is specific to COG5 or general to COG deficiency unknown","Single-lab study"]},{"year":2024,"claim":"Characterization of the COG5 p.Leu100Phe variant showed that a single missense mutation can destabilize the protein and abolish the COG5–COG7 interaction, linking patient pathology to disruption of this specific subunit interface.","evidence":"Co-immunoprecipitation in patient-derived cells with in silico structural analysis","pmids":["38987656"],"confidence":"Medium","gaps":["Single co-IP without reciprocal validation","Protein stability quantification was computational, not biophysical","Rescue experiment not performed"]},{"year":2026,"claim":"Revealing that COG5 deficiency elevates cellular copper, disrupts iron–sulfur cluster function and mitochondrial complex I assembly—rescuable by copper chelation—uncovered an unexpected link between Golgi tethering and mitochondrial bioenergetics via copper homeostasis.","evidence":"Proteomics, OXPHOS biochemistry, copper measurements, and dual rescue (COG5 re-expression and copper chelator) in COG5-deficient and patient-derived cells","pmids":["41824529"],"confidence":"High","gaps":["Identity of the copper transporter(s) mis-trafficked upon COG5 loss not determined","Whether copper dysregulation is common to all COG subunit deficiencies unclear","In vivo validation in animal models not reported"]},{"year":null,"claim":"Key open questions include how COG5 engages SNARE and Rab machinery to specify vesicle tethering, whether COG5's roles in copper homeostasis and UPR activation are shared by all lobe B subunits, and which copper transporter(s) are mis-trafficked when COG5 is lost.","evidence":"","pmids":[],"confidence":"Low","gaps":["SNARE/Rab binding interfaces on COG5 unresolved","Tissue-specific phenotypic mechanisms (e.g., neurodegeneration) not dissected","Full-length structural context of COG5 within the intact octameric complex lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,4]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,1,2,3,5]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2,3,4]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,5]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[3,7]}],"complexes":["COG complex (lobe B)"],"partners":["COG7","COG6","COG8","COG1"],"other_free_text":[]},"mechanistic_narrative":"COG5 is a lobe B subunit of the conserved oligomeric Golgi (COG) tethering complex that maintains Golgi structure and function by mediating retrograde intra-Golgi and ER-to-Golgi vesicle trafficking, thereby ensuring proper glycosylation of secretory cargo. COG5 adopts a CATCHR (complexes associated with tethering containing helical rods) fold and forms a stable subcomplex with COG7 via a conserved interface whose disruption impairs Golgi trafficking and glycosylation [PMID:25331899, PMID:16051600]. Beyond its canonical Golgi tethering role, COG5 deficiency elevates cellular copper levels, disrupting mitochondrial iron–sulfur cluster function and complex I assembly—defects rescuable by COG5 re-expression or copper chelation—and triggers Golgi fragmentation with UPR/PERK activation and downstream DNA damage [PMID:41824529, PMID:33277529]. Loss-of-function mutations in COG5 cause a congenital disorder of glycosylation (CDG) characterized by defective N- and O-glycan sialylation, confirmed by functional rescue with wild-type COG5 cDNA in patient fibroblasts [PMID:19690088]."},"prefetch_data":{"uniprot":{"accession":"Q9UP83","full_name":"Conserved oligomeric Golgi complex subunit 5","aliases":["13S Golgi transport complex 90 kDa subunit","GTC-90","Component of oligomeric Golgi complex 5","Golgi transport complex 1"],"length_aa":860,"mass_kda":94.9,"function":"Required for normal Golgi function","subcellular_location":"Cytoplasm, cytosol; Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q9UP83/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/COG5","classification":"Not Classified","n_dependent_lines":159,"n_total_lines":1208,"dependency_fraction":0.1316225165562914},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/COG5","total_profiled":1310},"omim":[{"mim_id":"614576","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L","url":"https://www.omim.org/entry/614576"},{"mim_id":"613612","title":"CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I","url":"https://www.omim.org/entry/613612"},{"mim_id":"606979","title":"COMPONENT OF OLIGOMERIC GOLGI COMPLEX 8; COG8","url":"https://www.omim.org/entry/606979"},{"mim_id":"606978","title":"COMPONENT OF OLIGOMERIC GOLGI COMPLEX 7; COG7","url":"https://www.omim.org/entry/606978"},{"mim_id":"606977","title":"COMPONENT OF OLIGOMERIC GOLGI COMPLEX 6; COG6","url":"https://www.omim.org/entry/606977"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Golgi apparatus","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/COG5"},"hgnc":{"alias_symbol":["GTC90"],"prev_symbol":["GOLTC1"]},"alphafold":{"accession":"Q9UP83","domains":[{"cath_id":"-","chopping":"285-302_325-438_461-469","consensus_level":"medium","plddt":85.7977,"start":285,"end":469},{"cath_id":"-","chopping":"480-564_571-595","consensus_level":"medium","plddt":91.5043,"start":480,"end":595},{"cath_id":"1.20.58,1.10.357","chopping":"596-738","consensus_level":"medium","plddt":91.8744,"start":596,"end":738},{"cath_id":"-","chopping":"760-839","consensus_level":"medium","plddt":92.8446,"start":760,"end":839},{"cath_id":"1.20.5","chopping":"52-165","consensus_level":"medium","plddt":81.6138,"start":52,"end":165}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UP83","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UP83-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UP83-F1-predicted_aligned_error_v6.png","plddt_mean":83.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=COG5","jax_strain_url":"https://www.jax.org/strain/search?query=COG5"},"sequence":{"accession":"Q9UP83","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UP83.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UP83/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UP83"}},"corpus_meta":[{"pmid":"12529436","id":"PMC_12529436","title":"The Drosophila Cog5 homologue is required for cytokinesis, cell elongation, and assembly of specialized Golgi architecture during spermatogenesis.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12529436","citation_count":103,"is_preprint":false},{"pmid":"19690088","id":"PMC_19690088","title":"Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19690088","citation_count":94,"is_preprint":false},{"pmid":"16051600","id":"PMC_16051600","title":"Genetic analysis of the subunit organization and function of the conserved oligomeric golgi (COG) complex: studies of COG5- and COG7-deficient mammalian cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16051600","citation_count":74,"is_preprint":false},{"pmid":"23228021","id":"PMC_23228021","title":"COG5-CDG: expanding the clinical spectrum.","date":"2012","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23228021","citation_count":38,"is_preprint":false},{"pmid":"23430875","id":"PMC_23430875","title":"COG5-CDG with a Mild Neurohepatic Presentation.","date":"2011","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/23430875","citation_count":33,"is_preprint":false},{"pmid":"20804914","id":"PMC_20804914","title":"Fusion of HMGA2 to COG5 in uterine leiomyoma.","date":"2010","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20804914","citation_count":29,"is_preprint":false},{"pmid":"11929878","id":"PMC_11929878","title":"Sec34 is implicated in traffic from the endoplasmic reticulum to the Golgi and exists in a complex with GTC-90 and ldlBp.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11929878","citation_count":23,"is_preprint":false},{"pmid":"25331899","id":"PMC_25331899","title":"Cog5-Cog7 crystal structure reveals interactions essential for the function of a multisubunit tethering complex.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25331899","citation_count":19,"is_preprint":false},{"pmid":"32174980","id":"PMC_32174980","title":"Identification of Two Novel Mutations in COG5 Causing Congenital Disorder of Glycosylation.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32174980","citation_count":16,"is_preprint":false},{"pmid":"33187827","id":"PMC_33187827","title":"Fetal glycosylation defect due to ALG3 and COG5 variants detected via amniocentesis: Complex glycosylation defect with embryonic lethal phenotype.","date":"2020","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33187827","citation_count":12,"is_preprint":false},{"pmid":"28960046","id":"PMC_28960046","title":"A Mild Form of COG5 Defect Showing Early-Childhood-Onset Friedreich's-Ataxia-Like Phenotypes with Isolated Cerebellar Atrophy.","date":"2017","source":"Journal of Korean medical science","url":"https://pubmed.ncbi.nlm.nih.gov/28960046","citation_count":12,"is_preprint":false},{"pmid":"31572517","id":"PMC_31572517","title":"Novel compound heterozygous COG5 mutations in a Chinese male patient with severe clinical symptoms and type IIi congenital disorder of glycosylation: A case report.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31572517","citation_count":8,"is_preprint":false},{"pmid":"33277529","id":"PMC_33277529","title":"COG5 variants lead to complex early onset retinal degeneration, upregulation of PERK and DNA damage.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33277529","citation_count":6,"is_preprint":false},{"pmid":"37064333","id":"PMC_37064333","title":"The First Congenital Disorders of Glycosylation Patient (Fetus) with Homozygous COG5 c.95T>G Variant.","date":"2023","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/37064333","citation_count":2,"is_preprint":false},{"pmid":"38559322","id":"PMC_38559322","title":"Novel mutation of COG5 in a Taiwanese girl with congenital disorders of glycosylation manifesting as developmental delay.","date":"2024","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/38559322","citation_count":1,"is_preprint":false},{"pmid":"41952427","id":"PMC_41952427","title":"Novel Compound Heterozygous Variants in the COG5 Gene Causing Fetal Hydrops and Skeletal Dysplasia.","date":"2026","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41952427","citation_count":0,"is_preprint":false},{"pmid":"41824529","id":"PMC_41824529","title":"COG5 deficiency disrupts cellular copper homeostasis and underlies the impaired mitochondrial OXPHOS function.","date":"2026","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41824529","citation_count":0,"is_preprint":false},{"pmid":"38987656","id":"PMC_38987656","title":"Characterization of a missense variant in COG5 in a Tunisian patient with COG5-CDG syndrome and insights into the effect of non-synonymous variants on COG5 protein.","date":"2024","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38987656","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.20.629825","title":"Killer Toxin K28 resistance in yeast relies on COG complex mediated trafficking of the defence factor Ktd1","date":"2024-12-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.20.629825","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10824,"output_tokens":2415,"usd":0.034348},"stage2":{"model":"claude-opus-4-6","input_tokens":5730,"output_tokens":2282,"usd":0.12855},"total_usd":0.162898,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Drosophila Cog5 homologue (Fws) localizes to Golgi structures throughout spermatogenesis and is required for cleavage furrow ingression during spermatocyte cytokinesis, cell elongation in spermatids, and assembly of the Golgi-based acroblast, consistent with a role in facilitating vesicle traffic through the Golgi to support rapid increases in cell surface area.\",\n      \"method\": \"Loss-of-function genetic analysis, immunofluorescence localization, phenotypic analysis of dividing spermatocytes and differentiating spermatids\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined cellular phenotypes and direct localization; replicated across multiple developmental stages\",\n      \"pmids\": [\"12529436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mammalian Sec34 (a COG complex subunit) localizes to the Golgi apparatus, participates in ER-to-Golgi transport (anti-Sec34 antibodies inhibit VSVG transport in a semi-intact cell assay), and physically interacts with GTC-90 and ldlBp/ldlCp as part of the same multisubunit complex; direct interactions of Sec34 with ldlBp and ldlCp were demonstrated in vitro.\",\n      \"method\": \"Immunofluorescence, semi-intact cell transport assay with neutralizing antibodies, large-scale immunoprecipitation from rat liver cytosol, in vitro binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — functional blocking antibody in reconstituted transport assay plus direct in vitro binding, multiple orthogonal methods in single study\",\n      \"pmids\": [\"11929878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"COG5 (Cog5) forms a stable subcomplex with Cog6 and Cog7 (lobe B), distinct from the Cog1–4 (lobe A) subcomplex; Cog8 bridges both subcomplexes into the complete COG complex; Cog5 deficiency causes mild Golgi cisternae dilation and partial glycosylation defects but not the full spectrum seen with Cog1/Cog2 loss, indicating subunit-specific roles. Only one or two of the Cog1/Cog2-dependent GEAR proteins are also sensitive to Cog5 deficiency.\",\n      \"method\": \"RNA interference knockdown of Cog5 in HeLa cells, immunoblotting, gel filtration, immunofluorescence microscopy, comparison with Cog1/Cog2 null CHO cells and Cog7-deficient fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (gel filtration, immunoblot, immunofluorescence, functional glycosylation assay) with isogenic comparisons; supported by accompanying in vitro study\",\n      \"pmids\": [\"16051600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of COG5 protein (due to a splicing mutation causing exon skipping) delays retrograde Golgi-to-ER trafficking as measured by brefeldin-A treatment of patient fibroblasts, and causes defective N- and O-glycan sialylation; re-expression of wild-type COG5 cDNA restores normal trafficking kinetics.\",\n      \"method\": \"Brefeldin-A retrograde trafficking assay in patient fibroblasts, serum glycoprotein analysis, rescue by wild-type COG5 cDNA transfection\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue experiment with defined cellular phenotype and multiple glycosylation readouts\",\n      \"pmids\": [\"19690088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Crystal structure of the Cog5–Cog7 complex reveals that Cog5 adopts a CATCHR (complexes associated with tethering containing helical rods) fold, homologous to subunits of the Dsl1, exocyst, and GARP complexes. The Cog5–Cog7 interface is conserved from yeast to humans, and disruption of this interface in human cells causes defects in Golgi trafficking and glycosylation.\",\n      \"method\": \"X-ray crystallography of Cog5–Cog7 complex, biochemical interaction assays, functional studies in human cells with interface-disrupting mutations\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validated in functional cellular assays; multiple orthogonal methods\",\n      \"pmids\": [\"25331899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"COG5 variants cause fragmentation of the Golgi apparatus and upregulation of the UPR modulator PERK (PKR-like ER kinase), which in turn induces DNA damage in cultured cells and in murine retina, identifying a role for COG5 in maintaining ER protein homeostasis.\",\n      \"method\": \"Patient-derived cells with COG5 variants, immunofluorescence for Golgi morphology, western blotting for PERK and DNA damage markers, murine retinal analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple readouts (Golgi morphology, UPR activation, DNA damage) in patient cells and mouse model, but single lab\",\n      \"pmids\": [\"33277529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A missense variant (p.Leu100Phe) in COG5 disrupts protein solubility and stability and abrogates the COG5–COG7 protein–protein interaction, as confirmed by co-immunoprecipitation in patient-derived cells.\",\n      \"method\": \"Co-immunoprecipitation in patient-derived cells, in silico structural analysis of COG5 variant effects on stability and solubility\",\n      \"journal\": \"Journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP from patient cells demonstrating loss of COG5–COG7 interaction, supported by in silico solubility/stability data\",\n      \"pmids\": [\"38987656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"COG5 deficiency leads to elevated cellular copper levels, which disrupts mitochondrial iron-sulfur cluster function and causes complex I assembly defects, resulting in impaired mitochondrial OXPHOS; these defects can be rescued by restoring COG5 expression or by copper chelation.\",\n      \"method\": \"Proteomic analysis of COG5-deficient and rescue cell models, biochemical validation of OXPHOS complex content, copper level measurements, copper chelator rescue experiments, patient-derived cells with COG5 variants\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical rescue by both genetic (COG5 re-expression) and pharmacological (copper chelator) means, with proteomic and functional OXPHOS readouts across multiple cell models\",\n      \"pmids\": [\"41824529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In yeast, all lobe B COG subunits (Cog5–Cog8) are required for resistance to killer toxin K28; COG complex lobe B is needed for proper trafficking of the endolysosomal defence factor Ktd1, and its mis-localization in cog mutants accounts for hypersensitivity to the toxin beyond effects on surface glycosylation.\",\n      \"method\": \"High-throughput K28 sensitivity assay, fluorescence microscopy of Ktd1 localization in cog mutant yeast\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay plus direct localization in genetic mutants; preprint, yeast ortholog\",\n      \"pmids\": [\"bio_10.1101_2024.12.20.629825\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"COG5 is a lobe B subunit of the conserved oligomeric Golgi (COG) tethering complex that adopts a CATCHR fold and directly interacts with COG7; it mediates retrograde intra-Golgi trafficking to maintain Golgi glycosyltransferase localization and glycoprotein glycosylation, participates in ER-to-Golgi vesicle tethering, supports membrane remodeling during cytokinesis and cell elongation (in Drosophila), and additionally regulates cellular copper homeostasis to sustain mitochondrial OXPHOS complex I assembly.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"COG5 is a lobe B subunit of the conserved oligomeric Golgi (COG) tethering complex that maintains Golgi structure and function by mediating retrograde intra-Golgi and ER-to-Golgi vesicle trafficking, thereby ensuring proper glycosylation of secretory cargo. COG5 adopts a CATCHR (complexes associated with tethering containing helical rods) fold and forms a stable subcomplex with COG7 via a conserved interface whose disruption impairs Golgi trafficking and glycosylation [PMID:25331899, PMID:16051600]. Beyond its canonical Golgi tethering role, COG5 deficiency elevates cellular copper levels, disrupting mitochondrial iron–sulfur cluster function and complex I assembly—defects rescuable by COG5 re-expression or copper chelation—and triggers Golgi fragmentation with UPR/PERK activation and downstream DNA damage [PMID:41824529, PMID:33277529]. Loss-of-function mutations in COG5 cause a congenital disorder of glycosylation (CDG) characterized by defective N- and O-glycan sialylation, confirmed by functional rescue with wild-type COG5 cDNA in patient fibroblasts [PMID:19690088].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that the COG complex participates in ER-to-Golgi transport answered whether this tethering complex functions only in intra-Golgi recycling or also in anterograde traffic from the ER.\",\n      \"evidence\": \"Neutralizing anti-Sec34 antibodies inhibited VSVG transport in a semi-intact cell assay; co-IP and in vitro binding identified COG subunit interactions\",\n      \"pmids\": [\"11929878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific contribution of COG5 versus other subunits to ER-to-Golgi tethering was not resolved\", \"In vitro transport reconstitution with purified COG complex not performed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration that the Drosophila COG5 orthologue Fws is required for Golgi-dependent membrane remodeling during cytokinesis and spermatid elongation revealed that COG5 function extends beyond steady-state trafficking to rapid membrane expansion events.\",\n      \"evidence\": \"Loss-of-function mutant analysis with immunofluorescence localization in Drosophila spermatocytes and spermatids\",\n      \"pmids\": [\"12529436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian COG5 has analogous roles in cytokinesis was not tested\", \"Vesicle cargo identity at the cleavage furrow unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping COG5 to a stable lobe B subcomplex (COG5–6–7) bridged to lobe A by COG8 defined the modular architecture of the COG complex and showed that lobe B loss produces milder glycosylation defects than lobe A loss.\",\n      \"evidence\": \"siRNA knockdown in HeLa cells combined with gel filtration, immunoblotting, and glycosylation analysis compared to Cog1/Cog2 null CHO cells\",\n      \"pmids\": [\"16051600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the COG5–COG6 interaction within lobe B remained unresolved\", \"Functional redundancy among lobe B subunits not fully tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of a COG5 splicing mutation in a CDG patient with defective retrograde Golgi trafficking, rescuable by wild-type COG5 re-expression, established COG5 as a disease gene and directly linked its function to glycosylation homeostasis in humans.\",\n      \"evidence\": \"Brefeldin-A trafficking assay in patient fibroblasts, serum glycoprotein profiling, and genetic rescue\",\n      \"pmids\": [\"19690088\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which partial COG5 loss selectively affects sialylation over other glycosylation steps unclear\", \"Neurological pathogenesis not mechanistically explained\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The crystal structure of the COG5–COG7 complex revealed a CATCHR fold for COG5 and showed that the conserved COG5–COG7 interface is essential for Golgi trafficking, unifying COG with other CATCHR tethering complexes structurally.\",\n      \"evidence\": \"X-ray crystallography, interface-disrupting mutagenesis with functional assays in human cells\",\n      \"pmids\": [\"25331899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length COG5 structure not obtained\", \"How COG5 engages SNARE or Rab proteins was not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Discovery that COG5 variants cause Golgi fragmentation and PERK-mediated UPR activation leading to DNA damage expanded the downstream consequences of COG5 dysfunction beyond glycosylation to ER proteostasis and genome integrity.\",\n      \"evidence\": \"Patient-derived cells and murine retina analyzed by immunofluorescence, western blot for PERK and DNA damage markers\",\n      \"pmids\": [\"33277529\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from Golgi fragmentation to PERK activation not mechanistically dissected\", \"Whether UPR activation is specific to COG5 or general to COG deficiency unknown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Characterization of the COG5 p.Leu100Phe variant showed that a single missense mutation can destabilize the protein and abolish the COG5–COG7 interaction, linking patient pathology to disruption of this specific subunit interface.\",\n      \"evidence\": \"Co-immunoprecipitation in patient-derived cells with in silico structural analysis\",\n      \"pmids\": [\"38987656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single co-IP without reciprocal validation\", \"Protein stability quantification was computational, not biophysical\", \"Rescue experiment not performed\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Revealing that COG5 deficiency elevates cellular copper, disrupts iron–sulfur cluster function and mitochondrial complex I assembly—rescuable by copper chelation—uncovered an unexpected link between Golgi tethering and mitochondrial bioenergetics via copper homeostasis.\",\n      \"evidence\": \"Proteomics, OXPHOS biochemistry, copper measurements, and dual rescue (COG5 re-expression and copper chelator) in COG5-deficient and patient-derived cells\",\n      \"pmids\": [\"41824529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the copper transporter(s) mis-trafficked upon COG5 loss not determined\", \"Whether copper dysregulation is common to all COG subunit deficiencies unclear\", \"In vivo validation in animal models not reported\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include how COG5 engages SNARE and Rab machinery to specify vesicle tethering, whether COG5's roles in copper homeostasis and UPR activation are shared by all lobe B subunits, and which copper transporter(s) are mis-trafficked when COG5 is lost.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"SNARE/Rab binding interfaces on COG5 unresolved\", \"Tissue-specific phenotypic mechanisms (e.g., neurodegeneration) not dissected\", \"Full-length structural context of COG5 within the intact octameric complex lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2, 3, 4]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [3, 7]}\n    ],\n    \"complexes\": [\n      \"COG complex (lobe B)\"\n    ],\n    \"partners\": [\n      \"COG7\",\n      \"COG6\",\n      \"COG8\",\n      \"COG1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}